Latest Stock Market News

On the options front, the highest Call Open Interest (OI) is positioned at the 23,000 strike, followed by the 22,700 strike, while the highest Put Open Interest (OI) is placed at the 22,000 strike, with additional interest at the 22,500 strike.

Axis Securities rates HCL Technologies with a target price of Rs 2,175. The current market price is Rs 1,569.35. HCL Tech has strong revenue visibility due to long-term contracts but faces challenges from economic uncertainties. Promoters hold a 60.81% stake, while FIIs own 19.38% and DIIs 15.16% as of 31-Dec-2024.

Defence stocks are rebounding due to Europe s $850 billion rearmament plan. Indian defence companies like Zen Technologies and Bharat Dynamics are witnessing gains. India s defence exports, bolstered by Make In India, are projected to grow significantly. Long-term investment in this sector looks promising despite short-term market uncertainties.

We have been fortunate enough to be associated with the entire journey of passive investing in India due to association with Benchmark AMC which pioneered this space in India.

JM Financial recommends buying Chalet Hotels with a target price of Rs 960, given its strong performance in the last quarter with a 21.21% increase in total income. Chalet Hotels, a mid-cap company in the Tourism & Hospitality sector, has also seen significant growth driven by economic trends and a strong propensity for travel.

Arvind Sanger discusses India s market performance amid global economic uncertainties, highlighting the role of domestic actions by the government, regulators, and central bank. He suggests patience for Indian investors, with opportunities in domestic consumption and high-quality financials, while noting potential challenges for Indian IT stocks due to AI advancements.

Deepak Shenoy, Founder of Capital Mind, predicts market volatility in the coming month due to global tariffs on steel and aluminium. He advises investors to be cautious, watch for positive trends, and avoid rushing into investments. He highlights sector-specific opportunities and emphasizes careful stock selection rather than a blanket market approach.

Anupam Rasayan India s shares will be in focus following a 10-year LOI with a Korean multinational for specialty chemicals worth $106 million, expected to commence from FY26. This deal highlights the company s strong R&D capabilities and presence in high-growth markets. CEO Gopal Agrawal emphasizes the company s commitment to innovation and reliability in global supply chains.

Syngene International announced acquiring its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 million. This acquisition will boost Syngene s bioreactor capacity to 50,000 liters, enhancing its large molecule discovery and manufacturing capabilities. While the move is strategic, it may temporarily affect operating margins.